Study: Babies’ poor vision may help organize visual brain pathways
MIT researchers found that low-quality visual input early in life may contribute to the development of key pathways in the brain’s visual system.
MIT researchers found that low-quality visual input early in life may contribute to the development of key pathways in the brain’s visual system.
The Substance Use Disorders Ventures Bootcamp ignites innovators like Evan Kharasch to turn research breakthroughs into treatments for substance use disorder.
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
In an annual tradition, MIT affiliates embarked on a trip to Washington to explore federal lawmaking and advocate for science policy.
Researchers also found these effects can be reversed by treatment with an antioxidant.
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
MIT chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world’s deadliest pathogen.
Informal help is a huge share of elder care in the U.S., a burden that is only set to expand. A new book explores different countries’ solutions.
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
The circuits could help researchers develop new treatments for fragile X syndrome and other diseases caused by mutations of a single gene.
MIT biologists have found that defects in some transfer RNA molecules can lead to the formation of these common conditions.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.